FDANot Yet Classified · Drug · FDA event 99296; recall number pending · Recalled July 8, 2026

Glucagon Emergency Kit for Low Blood Sugar recall — Lupin Pharmaceuticals Inc.

Agency report date: July 8, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named: Glucagon Emergency Kit for Low Blood Sugar
Company / brand: Lupin Pharmaceuticals
Lot / serial / date codes: Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.
Distribution: Nationwide within the U.S.

Agency product description and boundaries

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Affected product: Glucagon Emergency Kit for Low Blood Sugar

3. Open the official notice or contact

View the official FDA enforcement record (openFDA) ↗

Official recall ID: Not yet assigned by the FDA — identified by FDA event ID 99296
Brand: Lupin Pharmaceuticals
Classification: Not Yet Classified
Units affected: 64,894 units
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Affected products

Glucagon Emergency Kit for Low Blood Sugar

Companies & origin

Recalling firm location: Naples, FL, United States
Firm address: 5801 Pelican Bay Blvd Ste 500, N/A, 34108-2734

Identifying details (verbatim from the notice)

Product codes / lots: Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.
Distribution: Nationwide within the U.S.
Firm notified the public via: E-Mail
FDA event ID: 99296
Recall initiated: June 23, 2026
FDA report date: July 8, 2026

Verify with the official sources:

CPSC — consumer products ↗ (aggregated here)
NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
FDA — food, drugs, medical devices ↗ (aggregated here)
USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
Recalls.gov — the U.S. government’s all-agency portal ↗

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved July 27, 2026 at 7:00 PM UTC.

Report a data error on this page